Open access
Sep 2026
Stem cell morphology defines functional heterogeneity and therapeutic vulnerabilities in glioblastoma.
BACKGROUND Glioblastoma (GBM) is an aggressive brain tumor and an unmet clinical need due to its invasiveness and therapy resistance. These features are driven by glioblastoma stem-like cells (GSLCs), which exhibit remarkable functional heterogeneity. While transcriptional profiling has helped define this heterogeneity...
C. Barelli, M. Bonfanti, F. Mirabella et al.
· Neuro-Oncology · 0 citations